CITRAVESCENT granules sachet (reformulation)

Active ingredient:

sodium bicarbonate, Quantity: 1.32 g; citric acid, Quantity: 1.23 g; tartaric acid, Quantity: 0.4 g; sodium carbonate, Quantity: 0.08 g

Available from:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN (International Name):

citric acid,sodium bicarbonate,sodium carbonate,tartaric acid

Pharmaceutical form:

Granules, effervescent

Composition:

Excipient Ingredients: lactose monohydrate; sucrose

Administration route:

Oral

Units in package:

8 sachets, 10 sachets, 25 sachets, 28 sachets, 20 sachets

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

Systemic and urinary alkalinisation where indicated in the relief of symptoms associated with urinary tract infections such as cystitis, pyelonephritis, urethritis; and in reducing the formation of uric acid and cystine calculi. Citravescent may increase the effectiveness of sulphonamide antibiotics in the treatment of urinary tract infection. Acid indigestion or heartburn.

Product summary:

Visual Identification: White granules; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2013-08-15